← Back to Search

Increased Protein Intake (Eggs) for Cancer Recovery

N/A
Recruiting
Led By Vera Mazurak, PhD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must be ≥18 years of age
Histopathologically confirmed cancer with receipt of a platinum chemotherapy during treatment; active treatment has concluded
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline at 8 weeks
Awards & highlights

Study Summary

This trial will assess if eating ≥2 eggs a day can help restore nutritional status, improve immune function & quality of life in cancer patients post-treatment.

Who is the study for?
This trial is for adults over 18 who've finished platinum chemotherapy for cancer, can eat on their own, and are willing to follow the study plan. It's not for those allergic to eggs, fed by tubes or IV nutrition, with brain cancer or conditions affecting food consumption or nutrient metabolism.Check my eligibility
What is being tested?
The study tests if adding at least two eggs daily to the diet of cancer patients post-treatment can improve protein intake, immune function, and quality of life. Participants are randomly assigned to start this egg-enriched diet either immediately or after four weeks.See study design
What are the potential side effects?
Since the intervention involves common dietary items like eggs, side effects may be minimal but could include potential allergic reactions in individuals sensitive to eggs.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have completed treatment with platinum-based chemotherapy for my confirmed cancer.
Select...
I can eat semi-solid foods by myself and can continue to do so.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline at 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline at 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in mean cumulative protein intake between the two groups at 8 weeks.
Difference in mean cumulative protein intake within a group at 8 weeks for each group.
Secondary outcome measures
Change in Body weight
Change in Energy Intake
Change in Nutritional status and Symptom severity.
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Early InterventionExperimental Treatment1 Intervention
Participants are expected to begin intervention immediately after the completion of treatment for a period of 8 weeks.
Group II: Delayed InterventionExperimental Treatment1 Intervention
Participants are expected to begin intervention 4 weeks after the completion of the treatment, for a period of 4 weeks (weeks 5-8).

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
886 Previous Clinical Trials
384,688 Total Patients Enrolled
Egg Farmers of CanadaUNKNOWN
2 Previous Clinical Trials
180 Total Patients Enrolled
Vera Mazurak, PhDPrincipal InvestigatorUniversity of Alberta
2 Previous Clinical Trials
49 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots in the current trial for participants?

"Affirmative. Records hosted on clinicaltrials.gov validate that this medical experiment, which was initiated on September 1st 2023 is currently recruiting patients. The study requires 90 participants from a single research facility."

Answered by AI

How many people have enrolled in this research project?

"Affirmative. Clinicaltrials.gov's records demonstrate that the mentioned clinical trial, which was initially posted on September 1st 2023, is actively recruiting patients to participate in their research. There are 90 slots available at a single medical centre."

Answered by AI

What desired outcomes does this clinical trial intend to achieve?

"This trail seeks to measure the difference in mean cumulative protein intake within a group after 8 weeks from baseline. Secondary metrics include changes in energy consumption, quality of life (measured by Rand's Short Form 36-Item Health Survey 1.0), and nutritional status/symptom severity as determined by Patient Generated Subjective Global Assessments and Edmonton Symptom Assessment Scale - Revised Visual Analog Scales respectively."

Answered by AI
~42 spots leftby Dec 2024